The Human Vaccine Industry in Mexico: Post-Covid-19 Perspectives
Author Information
Author(s): Pérez-Hernández María del Pilar M., Castillo-Chávez Luis M.
Primary Institution: Instituto Politécnico Nacional
Hypothesis
How has the Covid-19 pandemic affected the vaccine production industry in Mexico?
Conclusion
The study concludes that Mexico's vaccine industry has lost its capacity for autonomy in vaccine manufacturing due to reduced investment and lack of public policies.
Supporting Evidence
- Vaccines have transformed global health and saved millions of lives.
- Mexico was once a leader in vaccine production but has seen a decline in its capabilities.
- The Covid-19 pandemic highlighted the vulnerabilities in Mexico's vaccine production.
- Investment in vaccine production has decreased significantly since the 1990s.
- Public policies are crucial for the development of local vaccine manufacturing capabilities.
Takeaway
Vaccines are super important for health, but Mexico used to make a lot of them and now struggles because it hasn't invested enough in making them.
Methodology
The study uses a critical literature review to analyze the technological and productive trajectory of the vaccine industry in Mexico.
Limitations
The study does not provide specific quantitative data on vaccine production capabilities.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website